5F-MDMB 2201

BUY 5F-MDMB-2201 ONLINE
5F-MDMB-2201 is an indazole-based synthetic cannabinoid that acts as a potent agonist of the CB₁ receptor. Thus ,it is sold online as a designer drug. Pfizer invented this drug in 2008. However,it is a potent cannabinoid agonists.

5F-MDMB-2201 is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA. A 4-fluorophenyl group substitutes the cyclohexyl group. Consequently,it has a high affinity ligand for the central CB1. It bears a cyclohexyl group,thus it is structurally related to AB-CHMINACA. However, the methyl ester group replaces the terminal aminocarbonyl moiety and the tert-butyl group substitutes the isobutyl moiety. This compound has unknown physiological and toxicological properties. Also, forensic and research applications are the uses of this product.